Micro-robotic percutaneous targeting of type II endoleaks in the angio-suite - Scorecard - MDSpire

Micro-robotic percutaneous targeting of type II endoleaks in the angio-suite

  • By

  • Gerlig Widmann

  • Johannes Deeg

  • Andreas Frech

  • Josef Klocker

  • Gudrun Feuchtner

  • Martin Freund

  • May 29, 2024

  • 0 min

Share

Clinical Scorecard: Percutaneous Micro-Robotic Approach for Targeting Type II Endoleaks in the Angio-Suite

At a Glance

CategoryDetail
ConditionType II endoleak after endovascular aneurysm repair (EVAR) of abdominal aortic aneurysm
Key MechanismsRetrograde filling of aneurysm sac via patent branch arteries causing persistent blood flow outside the graft
Target PopulationPatients with persistent and growing type II endoleaks after EVAR where transarterial access is not possible
Care SettingTertiary care angio-suite equipped with micro-robotic targeting platform and imaging modalities

Key Highlights

  • Type II endoleaks occur in approximately 9–30% of abdominal EVAR patients and may require treatment if sac enlargement >5 mm occurs.
  • Percutaneous direct puncture of the endoleak nidus under imaging guidance is an alternative when transarterial access is not feasible.
  • Micro-robotic arm-based targeting in the angio-suite enables precise, safe, and successful percutaneous puncture and embolization of type II endoleaks.

Guideline-Based Recommendations

Diagnosis

  • Use contrast-enhanced CT or MRI in native, arterial, and delayed phases to localize the perfused nidus of the type II endoleak.
  • Perform rotational C-arm CT in the angio-suite for procedural planning and target localization.

Management

  • Indicate treatment for type II endoleaks with sac enlargement >5 mm or persistent growth after EVAR.
  • Attempt transarterial embolization of feeding arteries when feasible; if not, proceed with percutaneous puncture.
  • Use micro-robotic targeting platform to guide percutaneous puncture and embolization with micro-coils and liquid embolic agents (e.g., Onyx®).

Monitoring & Follow-up

  • Perform contrast-enhanced CT or MRI the day after embolization to evaluate reduction in perfused endoleak volume.
  • Compare pre- and post-treatment imaging to assess embolization success.

Risks

  • Percutaneous puncture carries risks of organ perforation and bleeding due to difficult access and deep needle insertion.
  • Careful planning of needle trajectory is essential to avoid critical structures such as bowel, ureter, vena cava, and vessels.

Patient & Prescribing Data

Nine patients with persistent and growing type II endoleaks after infrarenal abdominal aortic aneurysm EVAR, unsuitable for transarterial treatment

Micro-robotic guided percutaneous embolization was feasible and safe, allowing precise targeting and successful occlusion of the endoleak nidus and feeding vessels.

Clinical Best Practices

  • Obtain multidisciplinary team consensus before intervention involving vascular surgeons and interventional radiologists.
  • Use high-resolution pre-procedural imaging (CT or MRI) for exact nidus localization and puncture route planning.
  • Employ micro-robotic arm-based targeting with fluoroscopic guidance to align needle trajectory and control insertion depth.
  • Confirm successful puncture by blood backflow and perform angiography to visualize endoleak and feeding branches before embolization.
  • Use a combination of micro-coils and liquid embolic agents to occlude feeding vessels and minimize inflow into the endoleak.

References

Original Source(s)

Related Content